Brief inpatient treatment continued by videoconference based psychotherapy for patients with chronic major depression

Organizational Data

DRKS-ID:
DRKS00009874
Recruitment Status:
Recruiting stopped (after recruiting started)
Date of registration in DRKS:
2016-01-29
Last update in DRKS:
2017-07-31
Registration type:
Retrospective

Acronym/abbreviation of the study

CBASP-VCP

URL of the study

No Entry

Brief summary in lay language

Aim of the project is to test the feasibility and acceptability of a combined treatment consisting of 3 week inpatient CBASP (Cognitive Behavioral Analysis System of Psychotherapy) -treatment and a 9 week outpatient CBASP-treatment using videoconference technology. During inpatient treatment patients undergo a medical and psychiatric examination and if necessary, medication is optimized according to the actual guide lines. Psychotherapeutic treatment starts and patients are introduced to the videoconference technique. After discharge the same therapist continues treatment via videoconference. A local ambulant psychiatrist will be involved in the treatment of the patient. Data collection will take place at four study centers at the same time. The pilot data sould provide the necessary data-base for the application of a larger randomized-controlled trial to conduct a cost-benefit-analysis in comparison to clinical routine treatment.

Brief summary in scientific language

Aim of the project is to test the feasibility and acceptability of a combined treatment consisting of 3 week inpatient CBASP (Cognitive Behavioral Analysis System of Psychotherapy) -treatment and a 9 week outpatient CBASP-treatment using videoconference technology.

Health condition or problem studied

Free text:
major chronic depression
ICD10:
F33 - Recurrent depressive disorder
Healthy volunteers:
No Entry

Interventions, Observational Groups

Arm 1:
Intervetniongroup: 3 weeks inpatient CBASP treatment (2 single therapy sessions of 50 min per week) with following videoconference based outpatient CBASP treatment for 9 weeks (2 single therapy sessions of 50 min per week).
Arm 2:
Historical comparison group from existing data of patients who participated in a classical 12 weeks inpatient CBASP treatment (2 single therapy sessions of 50 min per week plus 2 h of CBASP-group therapy per week) .

Endpoints

Primary outcome:
- Questionnaire on feasibility and acceptance. Completed by patients and therapists - Hamilton Rating Scale for Depression (HAMD-24; Hamilton, 1960) T0, T1, T2, T3 (T0 : at admission to station , T1 : at discharge from station , T2 : at end of outpatient therapy , follow-up ( T3 ) : 3 months after completion of outpatient therapy (end of study)
Secondary outcome:
- Structured Clinical Interview for DSM-IV Disorders (T0). - Childhood Trauma Questionnaire (T0). - Beck Depression Inventory (T0-T3). - Clinical Global Impression Scale (T1-T2). - Global Assessment of Functioning Scale (T1-T2). - World Health Organization Quality of Life Instrument (T0-T3). - Impact Message Inventory-R (therapist-patient-relationship) (T1-T2).

Study Design

Purpose:
No Entry
Allocation:
Non-randomized controlled study
Control:
  • Historical
Phase:
N/A
Study type:
Interventional
Mechanism of allocation concealment:
No Entry
Blinding:
No
Assignment:
Other
Sequence generation:
No Entry
Who is blinded:
No Entry

Recruitment

Recruitment Status:
Recruiting stopped (after recruiting started)
Reason if recruiting stopped or withdrawn:
Lack of funding

Recruitment Locations

Recruitment countries:
  • Germany
Number of study centers:
Multicenter study
Recruitment location(s):
  • University medical center Klinik für Psychiatrie und Psychotherapie Freiburg im Breisgau

Recruitment period and number of participants

Planned study start date:
No Entry
Actual study start date:
2015-10-06
Planned study completion date:
No Entry
Actual Study Completion Date:
No Entry
Target Sample Size:
30
Final Sample Size:
6

Inclusion Criteria

Sex:
All
Minimum Age:
18 Years
Maximum Age:
70 Years
Additional Inclusion Criteria:
- diagnosis of Chronic Depression - Hamilton Rating Scale of Depression (HRSD-24) score>20 - in ongoing medical/psychiatric care - age 18-70 years - fluent in German language - technical requirements (Internet access) - informed consent - treatment resistance (no response to two or more adequate trials of antidepressants and/or no response to at least two health-insurance-reimbursed psychotherapies with at least 22 sessions each).

Exclusion Criteria

- history of bipolar disorder - substance addiction (less than 3 months clean) - antisocial or borderline personality disorder - severe autism - organic brain disorders - severe physical illness - acute risk of suicide or suicide attempt within the last 12 months

Addresses

Primary Sponsor

Address:
Klinik für Psychiatrie und Psychotherapie. Uniklinik Freiburg
Dr. Lars Hölzel
79104 Freiburg
Germany
Telephone:
0761-270-69840
Fax:
No Entry
Contact per E-Mail:
Contact per E-Mail
URL:
No Entry
Investigator Sponsored/Initiated Trial (IST/IIT):
Yes

Contact for Scientific Queries

Address:
Universitätsklinikum FreiburgKlinik für Psychiatrie und Psychotherapie
Dr. Nicole Ower
Hauptstr. 5
79104 Freiburg
Germany
Telephone:
0761-27069841
Fax:
0761-27069890
Contact per E-Mail:
Contact per E-Mail
URL:
https://www.uniklinik-freiburg.de/psych.html

Contact for Public Queries

Address:
Universitätsklinikum FreiburgKlinik für Psychiatrie und Psychotherapie
Dr. Nicole Ower
Hauptstr. 5
79104 Freiburg
Germany
Telephone:
0761-27069841
Fax:
0761-27069890
Contact per E-Mail:
Contact per E-Mail
URL:
https://www.uniklinik-freiburg.de/psych.html

Principal Investigator

Address:
Universitätsklinikum FreiburgKlinik für Psychiatrie und Psychotherapie
Dr. Nicole Ower
Hauptstr. 5
79104 Freiburg
Germany
Telephone:
0761-27069841
Fax:
0761-27069890
Contact per E-Mail:
Contact per E-Mail
URL:
https://www.uniklinik-freiburg.de/psych.html

Sources of Monetary or Material Support

Public funding institutions financed by tax money/Government funding body (German Research Foundation (DFG), Federal Ministry of Education and Research (BMBF), etc.)

Address:
Ministerium für Wissenschaft, Fortschung und Kunst Baden-Württemberg
70029 Stuttgart
Germany
Telephone:
No Entry
Fax:
No Entry
Contact per E-Mail:
Contact per E-Mail
URL:
No Entry

Institutional budget, no external funding (budget of sponsor/PI)

Address:
Universitätsklinikum FreiburgKlinik für Psychiatrie und Psychotherapie
79104 Freiburg
Germany
Telephone:
No Entry
Fax:
No Entry
Contact per E-Mail:
Contact per E-Mail
URL:
No Entry

Ethics Committee

Address Ethics Committee

Address:
Ethik-Kommission der Albert-Ludwigs-Universität Freiburg
Engelberger Str. 21
79106 Freiburg
Germany
Telephone:
+49-761-27072600
Fax:
+49-761-27072630
Contact per E-Mail:
Contact per E-Mail
URL:
No Entry

Vote of leading Ethics Committee

Vote of leading Ethics Committee
Date of ethics committee application:
2015-05-22
Ethics committee number:
232/15
Vote of the Ethics Committee:
Approved
Date of the vote:
2015-08-18

Further identification numbers

Other primary registry ID:
No Entry
EudraCT Number:
No Entry
UTN (Universal Trial Number):
No Entry
EUDAMED Number:
No Entry

IPD - Individual Participant Data

Do you plan to make participant-related data (IPD) available to other researchers in an anonymized form?:
No Entry
IPD Sharing Plan:
No Entry

Study protocol and other study documents

Study protocols:
No Entry
Study abstract:
No Entry
Other study documents:
No Entry
Background literature:
No Entry
Related DRKS studies:
No Entry

Publication of study results

Planned publication:
No Entry
Publikationen/Studienergebnisse:
No Entry
Date of first publication of study results:
No Entry
DRKS entry published for the first time with results:
No Entry

Basic reporting

Basic Reporting / Results tables:
No Entry
Brief summary of results:
No Entry